Author:
Dempsey Amanda F.,Abraham Leah M.,Dalton Vanessa,Ruffin Mack
Reference40 articles.
1. U.S. Food and Drug Administration. Product Approval Information -Licensing Action, Gardasil; 2006. Available from: http://www.fda.gov/cber/products/hpvmer060806qa.htm Accessed August 1, 2006.
2. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions;N Engl J Med,2007
3. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials;Joura;Lancet,2007
4. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial;Villa;Lancet Oncol,2005
5. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up;Villa;Br J Cancer,2006
Cited by
164 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献